Related Experiment Videos
Clinical and histological differences in anaplastic thyroid carcinoma
J M Rodriguez1, A Piñero, S Ortiz
1Department of Surgery, Virgen de la Arrixaca University Hospital, Murcia, Spain.
The European Journal of Surgery = Acta Chirurgica
|February 25, 2000
Summary
Anaplastic thyroid cancer with coexisting differentiated thyroid cancer has a better prognosis than pure anaplastic thyroid cancer. This study highlights survival differences in these thyroid cancer subtypes.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Anaplastic thyroid carcinoma (ATC) is an aggressive malignancy.
- Distinguishing pure ATC from ATC with associated differentiated thyroid carcinoma is crucial for prognosis.
Purpose of the Study:
- To compare outcomes for patients with pure anaplastic thyroid carcinoma versus those with coexisting differentiated thyroid carcinoma.
- To identify prognostic factors in anaplastic thyroid cancer.
Main Methods:
- Retrospective study of 14 patients with anaplastic thyroid cancer over 26 years.
- Analysis of clinical data, treatment, histological findings, and patient follow-up.
- Categorization into pure ATC (7 patients) and associated ATC (7 patients).
Main Results:
- 13 of 14 tumors showed local spread.
- Mean survival was 14 months, significantly longer for associated ATC (24 months) compared to pure ATC (4 months).
- Two long-term survivors (61 and 70 months) both had associated anaplastic cancers.
Conclusions:
- A subgroup of anaplastic thyroid cancers coexists with better-differentiated thyroid carcinomas.
- This subgroup demonstrates a significantly better prognosis than primary pure anaplastic thyroid carcinoma.